Inflammasomes as mediators of immunity against influenza virus.
about
Activation of P2X(7) receptor by ATP plays an important role in regulating inflammatory responses during acute viral infectionInduction of innate immunity and its perturbation by influenza virusesRegulating the adaptive immune response to respiratory virus infectionActivation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and diseaseAsparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activationInfluenza and Memory T Cells: How to Awake the ForceImmune Responses to Influenza Virus and Its Correlation to Age and Inherited FactorsIntrinsic antiviral immunityThe effector T cell response to influenza infectionViral infection of the lung: host response and sequelaeMannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection.Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses.TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses.Innate immune response to a H3N2 subtype swine influenza virus in newborn porcine trachea cells, alveolar macrophages, and precision-cut lung slices.Pathogenic potential of interferon αβ in acute influenza infectionAIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and MortalityGeldanamycin Reduces Acute Respiratory Distress Syndrome and Promotes the Survival of Mice Infected with the Highly Virulent H5N1 Influenza Virus.Role of aging on innate responses to viral infections.Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems.Innate immune recognition of respiratory syncytial virus infection.The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.Activation and measurement of NLRP3 inflammasome activity using IL-1β in human monocyte-derived dendritic cellsIn silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.Tissue factor, blood coagulation, and beyond: an overview.A novel systems pharmacology model for herbal medicine injection: a case using Reduning injection.Virus-induced NETs--critical component of host defense or pathogenic mediator?Caspase-1 independent viral clearance and adaptive immunity against mucosal respiratory syncytial virus infection.Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients.Detection of prokaryotic mRNA signifies microbial viability and promotes immunity.IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8⁺ T cell responses to influenza A virusEffect of a synbiotic on the response to seasonal influenza vaccination is strongly influenced by degree of immunosenescenceControl of antiviral immunity by pattern recognition and the microbiome.Predicting Viral Infection From High-Dimensional Biomarker Trajectories.Induction of memory cytotoxic T cells to influenza A virus and subsequent viral clearance is not modulated by PB1-F2-dependent inflammasome activation.Traditional and new influenza vaccinesTowards multiscale modeling of influenza infectionThe Nlrp3 inflammasome promotes age-related thymic demise and immunosenescencePattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury.
P2860
Q21134608-0E12C9F0-AD1C-4668-AF11-B8BB42BB2F83Q26800014-AB9CADC6-5A48-4C91-B068-505F60DBC724Q27014696-AB0351A4-5CBE-4D03-9E85-6897D815CAF3Q27334659-8B9151E7-7999-4A55-801B-00649761D0E1Q27342989-19A4FC6E-1E53-4E42-9BD1-3667FD00ECCEQ28070255-C6F21624-825A-4632-B173-1892E57B54E7Q28075495-0104837E-FED0-45D8-8304-FB9662FA9AB0Q28709929-F947B93C-1938-4186-98BA-8A5AE25D3D00Q30361773-F55B8247-24CF-4BED-B3F5-5C276CCDD1A9Q30409296-A16087A6-B2E6-4FD7-AC65-6F58A0C811F5Q30409432-3096C40F-5EEB-42C6-87DB-735673A22C2AQ30409873-4B68776B-0DB2-4D6A-AA10-87F807C24F06Q30419734-22D8864F-D9D2-4422-BB98-CD7968CC15E1Q31126174-474C6044-A970-498C-9C8A-C24868EEE4AFQ33612279-E4AAA873-BAA4-492A-97CA-566836A551DAQ33663298-A7E90360-6D2A-4876-8E10-6465AD359F90Q33711002-3EE802D5-C6EB-4C5C-8ABB-9DF4FE11E576Q33799835-42E91D5B-5626-486D-BD3D-6EE11AFA6700Q34063443-BBB26D53-8370-4AD1-A472-AF7F493A2890Q34072291-E16FCEAE-0DB8-4A60-8A16-9ADE2A39F462Q34180049-62DE65AE-7E67-49CD-B5D2-353ADD3F27E5Q34313957-F3A10907-C611-4FF4-B1C1-C2AADDC9201DQ34360646-8F1044EB-A62B-4D8D-BD2C-A12409E332CFQ34700616-9880E6CD-144A-454F-A18E-FC981B50CD09Q35222618-5811F855-7C02-470C-B2C9-3283BC78D583Q35389260-0F24F1F8-8FB2-47BA-9BAE-E31DD9B8C472Q35539861-A3A59B38-1181-4C98-A582-92CAC9E03934Q35543920-497E18C5-0143-4E12-B24C-625DA69C4D6EQ35785935-E7E9CABD-9F39-45E5-9525-54350D47836AQ35789153-5FA6EFC6-C37C-4219-83D3-B4CE5C108F52Q36625188-02747FE3-F36A-4315-A2C3-EDC54E510089Q36691559-0A99D131-5A1A-427A-9999-DDD6D514715AQ36862008-451F880A-5633-4767-9DF0-FDA39836E007Q36862045-F70A4C13-3F13-45C3-9312-1BA0C6714299Q36959553-0ED99495-063D-415B-A210-24EA8FFD06EFQ37035833-2E5E1A60-EE54-4312-827A-397BC007BA90Q37136609-70EE38ED-7CD7-4217-81B3-B1261CFFF03AQ37444372-52B85A11-0CE6-4BD9-9DC4-252E2165D5F3Q37981769-05E3DC79-0936-4B2F-8DA6-8824A418B347Q37985804-4BD49031-45D0-48F8-934F-EE0134110551
P2860
Inflammasomes as mediators of immunity against influenza virus.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Inflammasomes as mediators of immunity against influenza virus.
@ast
Inflammasomes as mediators of immunity against influenza virus.
@en
Inflammasomes as mediators of immunity against influenza virus.
@nl
type
label
Inflammasomes as mediators of immunity against influenza virus.
@ast
Inflammasomes as mediators of immunity against influenza virus.
@en
Inflammasomes as mediators of immunity against influenza virus.
@nl
prefLabel
Inflammasomes as mediators of immunity against influenza virus.
@ast
Inflammasomes as mediators of immunity against influenza virus.
@en
Inflammasomes as mediators of immunity against influenza virus.
@nl
P2860
P356
P1433
P1476
Inflammasomes as mediators of immunity against influenza virus.
@en
P2093
Akiko Iwasaki
Iris K Pang
P2860
P356
10.1016/J.IT.2010.11.004
P577
2010-12-14T00:00:00Z